Professor of Neurology, Indiana University
Neurology
Dr. Edward J. Dropcho, MD
|
|
Give Review
Edward Dropcho practices Neurology. He studied medicine at University of Chicago Pritzker School of Medicine. University of Chicago Pritzker School of Medicine is ranked 10/19 in Research/PrimaryCare. He over the years received 1 awards: "Indianapolis Monthly". Edward Dropcho is also published. He has 51 publications published. The lastest publication: "Dose-intensification of procarbazine, CCNU (lomustine), vincristine (PCV) with peripheral blood stem cell support in young patients with gliomas.' He accepts Medicare payments and is listed with Medicare.gov.
Publications
- Neurologic complications of lung Cancer.
- Reduced T-lymphocyte cell reactivity as a function of human aging.
- Paraneoplastic opsoclonus-myoclonus. Association with medullary thyroid carcinoma and review of the literature.
- Phase I trial of the murine monoclonal anti-GD2 antibody 14G2a in metastatic melanoma.
- Chemotherapy for anaplastic oligodendroglioma. National Cancer Institute of Canada Clinical Trials Group.
- Improvement of paraneoplastic opsoclonus-myoclonus after protein A column therapy.
- Dose-intensification of procarbazine, CCNU (lomustine), vincristine (PCV) with peripheral blood stem cell support in young patients with Gliomas.
- A pilot study of dose-intensified procarbazine, CCNU, vincristine for poor prognosis Brain tumors utilizing fibronectin-assisted, retroviral-mediated modification of C...
- A phase III randomized prospective trial of external beam radiotherapy, mitomycin C, carmustine, and 6-mercaptopurine for the treatment of adults with anaplastic gliom...
- Neurotoxicity of Cancer chemotherapy.
- NeuroToxicity of radiation therapy.
- Paraneoplastic neuromuscular disorders-part 2.
- Paraneoplastic neuromuscular disorders-part I.
- Randomized phase II study of cilengitide, an integrin-targeting arginine-glycine-aspartic acid peptide, in recurrent glioblastoma multiforme.
- Orchiectomy for suspected microscopic tumor in patients with anti-Ma2-associated encephalitis.
- Antineuronal (anti-Ri) antibodies in a patient with steroid-responsive opsoclonus-myoclonus.
- Randomized comparison of diaziquone and carmustine in the treatment of adults with anaplastic glioma.
- Autoantibodies against the Hel-N1 RNA-binding protein among patients with lung carcinoma: an association with type I anti-neuronal nuclear antibodies.
- Paraneoplastic disorders: antineuronal antibodies and therapeutic options.
- Immunotherapy for paraneoplastic neurological disorders.
- Update on paraneoplastic Syndromes.
- Anti-Hu antibody Neuropathy: a clinical, electrophysiological, and pathological study.
- Antiphospholipid and glutamic acid decarboxylase antibodies in patients with focal Epilepsy.
- Neurologic paraneoplastic Syndromes.
- Novel chemotherapeutic approaches to Brain tumors.
- Remote neurologic manifestations of Cancer.
- Principles of paraneoplastic Syndromes.
- Phase II study of intracarotid or selective intracerebral infusion of cisplatin for treatment of recurrent anaplastic Gliomas.
- Anti-Hu-associated paraneoplastic sensory Neuropathy responding to early aggressive immunotherapy: report of two cases and review of literature.
- Autoimmune central Nervous system paraneoplastic disorders: mechanisms, diagnosis, and therapeutic options.
- The prognostic impact of prior low grade histology in patients with anaplastic Gliomas: a case-control study.
- Expression of Hel-N1 and Hel-N2 in small-cell lung carcinoma.
- Antiamphiphysin antibodies with small-cell lung carcinoma and paraneoplastic encephalomyelitis.
- Guidelines on the detection of paraneoplastic anti-neuronal-specific antibodies: report from the Workshop to the Fourth Meeting of the International Society of Neuro-I...
- Defective mitogenic responses in myasthenia gravis and Multiple sclerosis.
- Preradiation intracarotid cisplatin treatment of newly diagnosed anaplastic gliomas. The CNS Cancer Consortium.
- Ovulation in immature rats in relation to the time and dose of injected human chorionic gonadotropin or pregnant mare serum gonadotropin.
- Contrasting defects of T-lymphocyte mitogenic response in Multiple sclerosis and myasthenia gravis.
- Cloning of a Brain protein identified by autoantibodies from a patient with paraneoplastic cerebellar degeneration.
- Primary intraCranial rhabdomyosarcoma: case report and review of the literature.
- Supratentorial malignant Gliomas in childhood: a review of fifty cases.
- Systemic beta-interferon therapy for recurrent gliomas: a brief report.
- Characterization of a cDNA encoding a 34-kDa Purkinje neuron protein recognized by sera from patients with paraneoplastic cerebellar degeneration.
- The remote effects of cancer on the Nervous system.
- Neuronal antinuclear antibodies in a patient with Lambert-Eaton myasthenic Syndrome and small-cell lung carcinoma.
- Intracarotid cisplatin chemotherapy for recurrent Gliomas.
- Cerebellar Ataxia as a paraneoplastic syndrome.
- Paraneoplastic motor neuron Disease and renal cell carcinoma: improvement after nephrectomy.
- Steroid-induced weakness in patients with primary Brain tumors.
- Central Nervous system injury by therapeutic irradiation.
Schools
Indiana University School of Medicine
U Of Chgo Div Of Bio Sci Pritzker Sch Of Med
University Chicago Hosps
Johns Hopkins Hospital
Meml Sloan Kettering Cancer
Procedures Preformed
- EEG (Electroencephalogram)
Conditions Treated
- Ataxia
- Brain and Nervous System Cancer (incl. Gliomas, Astrocytoma, Schwannoma, Medulloblastoma, Chordoma)
- Brain Aneurysm
- Brain Injury
- View All
Doctors Specialties
- Neurology
Accepted Insurances
- Choice Plus POS II
- American Republic
- Pathway X Bronze Direct CACA IN HIX
- Anthem Blue Cross Blue Shield HMO
- Anthem Blue Cross Blue Shield PPO
- Blue Card PPO
- Blue Cross Blue Shield of Illinois PPO
- Cigna HMO
- Cigna PPO
- Great West Healthcare-Cigna PPO
- Open Access Plus
- Cofinity PPO
- Commercial Insurance Company
- First Health (Coventry Health Care) PPO
- HealthSmart
- Choice Care PPO
- MedHealthInsurance
- Medicaid
- Medical Mutual of Ohio
- Medicare MCR
- MultiPlan PPO
- PHCS Network PPO
- Sagamore Plus
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Options PPO
- United Healthcare
Awards
- Indianapolis Monthly
Education
-
Memorial Sloan-Kettering Cancer Center -
Johns Hopkins University -
University of Chicago -
University of Chicago Pritzker School of Medicine
Drug Facts
| NPI NUMBER | 1962424937 | |
| NPPES Provider LastName | DROPCHO | |
| NPPES Provider FirstName | EDWARD | |
| NPPES Provider ZIPCode | 462025112 | |
| NPPES Provider State | IN | |
| Specialty Description | Neurology | |
| Total Claim Count | 1078.0 | |
| Distinct Opioid Count | 4.0 | |
| Opioid Claim Count | 112.0 | |
| Percent Opioid Claims | 10.39 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1962424937 |
| Last Name Of The Provider | DROPCHO |
| First Name Of The Provider | EDWARD |
| View All |
Similar Doctors
|
|
Dr. Michael A. Sermersheim, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Karen D. Rodman, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Brandy R. Matthews, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Raymond J. Loffer, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ann Marie M. Hake, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kevin J. Puzio, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Cynthia H. Hingtgen, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jamie S. Street, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Devin D. Mackay, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Dragos Sabau, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Gaston Dacosta, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ryan M. Gleason, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Paul Bustion Jr., MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Richard V. Scheer, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ashley P. Ghiaseddin, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jeffrey C. Miller, MD |